While there's no single right way to taper, gradually reducing your dose with the guidance of your provider may help you avoid rapid weight regain and keep other benefits
Tirzepatide operates as a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, a class of medication that has been increasingly used in the treatment of Type 2 diabetes and weight management
PubMed Vidal SI, Akiska YM et al
Active Ingredient: Metformin Metformin is an oral biguanide that lowers blood sugar by reducing liver glucose production and improving insulin sensitivity
In SURPASS-2, which compared tirzepatide to semaglutide (a GLP-1 receptor agonist) in patients taking metformin, tirzepatide 5 mg, 10 mg, and 15 mg doses achieved mean HbA1c reductions of 2.01%, 2.24%, and 2.30% respectively from baseline, compared to 1.86% with semaglutide 1 mg
At Elite Primary Care Group, our experienced providers will work closely with you to select the most appropriate treatment, monitor your progress, and offer ongoing support to maximize your results
